# Lancet Review of Medical Cannabis in Mental Health – What the Study Shows > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/mental-health-cannabis-use-evidence-lancet-review/ > **Published:** 2026-03-24T15:53:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:57:47-04:00 > **Clinical Summary:** Explore mental health cannabis use evidence from the Lancet review highlighting gaps in clinical practice and research for psychiatric disorders. --- ✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchSafetyAnxiety Clinical Summary # Clinical Summary A recent Lancet review examining [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use in mental health conditions highlights a significant gap between clinical practice and the evidence base, revealing that cannabis is increasingly being used by patients with psychiatric disorders despite limited rigorous trial data supporting efficacy and safety in these populations. The review underscores clinician concerns that current research has not adequately characterized optimal dosing, cannabinoid ratios, or patient selection criteria for mental health indications, leaving prescribers and patients navigating treatment decisions with incomplete information. This evidence gap is particularly concerning given that mental health represents a substantial proportion of medical [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in jurisdictions where it is legal, yet most clinical guidance remains extrapolated from preclinical work or observational data rather than robust randomized controlled trials. For clinicians, this review reinforces the need for careful patient assessment, including psychiatric baseline evaluation and monitoring protocols, when considering cannabis for conditions like anxiety, depression, or PTSD. Patients seeking cannabis for mental health should be counseled transparently about the preliminary nature of evidence and the potential for adverse psychiatric effects, particularly in those with underlying psychotic vulnerability. Clinicians should advocate for higher-quality research while implementing conservative prescribing practices until stronger evidence emerges to guide mental health cannabis therapeutics. Dr. Caplan’s Take “What we’re seeing in clinical practice is that carefully selected patients with treatment-resistant anxiety or PTSD often respond meaningfully to cannabis, yet our research literature remains fragmented and our guidelines lag behind the evidence we’re generating at the bedside, which puts thoughtful physicians in an uncomfortable position of having to counsel patients based on clinical judgment rather than robust trials.” Clinical Perspective The growing gap between [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) use and robust evidence in mental health reflects a genuine tension in modern medicine: patients are accessing cannabis for conditions like anxiety and depression despite limited high-quality trials, while clinicians lack clear guidance on efficacy, optimal dosing, or patient selection. This evidence lag is complicated by regulatory barriers that have historically limited research, the heterogeneity of cannabis products (varying cannabinoid ratios, delivery methods, and contaminants), and the difficulty of conducting randomized controlled trials on a Schedule I substance in many jurisdictions. Furthermore, self-reported symptom improvement may reflect placebo effects, regression to the mean, or concurrent use of established psychiatric medications rather than cannabis-specific benefit. Given these uncertainties, clinicians encountering patients interested in or already using cannabis for mental health should maintain a stance of informed curiosity: take detailed histories of use patterns and perceived effects, screen for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) and contraindications (such as 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Lancet+Review+of+Medical+Cannabis+in+Mental+Health+-+What+the+Study+Shows+%40drcaplan&url=https%3A%2F%2Fcannabishealthnews.co.uk%2F2026%2F03%2F24%2Fwhat-lancet-review-of-medical-cannabis-in-mental-health-shows%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcannabishealthnews.co.uk%2F2026%2F03%2F24%2Fwhat-lancet-review-of-medical-cannabis-in-mental-health-shows%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Lancet+Review+of+Medical+Cannabis+in+Mental+Health+-+What+the+Study+Shows+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fcannabishealthnews.co.uk%2F2026%2F03%2F24%2Fwhat-lancet-review-of-medical-cannabis-in-mental-health-shows%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - Lancet Review of Medical Cannabis in Mental Health – What the Study Shows - [New York approves cannabis for anxiety. Science says it may not help – Times Union](https://cedclinic.com/new-york-cannabis-anxiety-approval/) - [Study finds few benefits from medical marijuana | WORLD – WNG.org](https://cedclinic.com/medical-cannabis-efficacy-review-mental-health/) 📰 Source: [https://cannabishealthnews.co.uk/2026/03/24/what-lancet-review-of-medical-cannabis-in-mental-health-shows/](https://cannabishealthnews.co.uk/2026/03/24/what-lancet-review-of-medical-cannabis-in-mental-health-shows/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Should cannabis be used for mental illnesses? – indica News](https://cedclinic.com/cannabinoid-efficacy-for-mental-health/) Explore the debate on cannabis use for mental illnesses and the current evidence supporting or opposing its use. [Read More](https://cedclinic.com/cannabinoid-efficacy-for-mental-health/) [Cannabinoid Clinical Trials for Mental & Substance Disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) Review ongoing and completed [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) investigating cannabinoids for mental health and substance use disorders. [Explore Trials](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) [Cannabis may backfire for mental health disorders, major study finds – Fox News](https://cedclinic.com/cannabis-use-disorder-strongly-linked-to-major-depression/) A major study highlights potential risks and adverse effects of cannabis use in mental health disorder patients. [Learn More](https://cedclinic.com/cannabis-use-disorder-strongly-linked-to-major-depression/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).